Cantor WJ - Search Results

1

Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial.

Cantor WJ, Tan M, Berwanger O, Lavi S, White HD, Nicolau JC, Dehghani P, Tajer CD, Lopes RD, Moia DDF, Nicholls SJ, Parkhomenko A, Averkov O, Brass N, Lutchmedial S, Malaga G, Damiani LP, Piegas LS, Granger CB, Goodman SG. Cantor WJ, et al. Am Heart J. 2022 Sep;251:1-12. doi: 10.1016/j.ahj.2022.05.005. Epub 2022 May 6. Am Heart J. 2022. PMID: 35533724 Clinical Trial.

2

Failed coronary stent deployment.

Cantor WJ, Lazzam C, Cohen EA, Bowman KA, Dolman S, Mackie K, Natarajan MK, Strauss BH. Cantor WJ, et al. Am Heart J. 1998 Dec;136(6):1088-95. doi: 10.1016/s0002-8703(98)70168-1. Am Heart J. 1998. PMID: 9842025

3

Highlights from the 71st American Heart Association Scientific Sessions: November 8 to 11, 1998.

Alexander JH, Kong DF, Cantor WJ. Alexander JH, et al. Among authors: cantor wj. Am Heart J. 1999 Mar;137(3):555-74. doi: 10.1016/s0002-8703(99)70506-5. Am Heart J. 1999. PMID: 10047641 No abstract available.

4

Results of recent large myocardial infarction trials, adjunctive therapies, and acute myocardial infarction: improving outcomes.

Cantor WJ, Ohman EM. Cantor WJ, et al. Cardiol Rev. 1999 Jul-Aug;7(4):232-44. doi: 10.1097/00045415-199907000-00015. Cardiol Rev. 1999. PMID: 10423675 Review.

5

The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.

Campbell KR, Ohman EM, Cantor W, Lincoff AM. Campbell KR, et al. Am J Cardiol. 2000 Apr 27;85(8A):32C-8C. doi: 10.1016/s0002-9149(00)00877-8. Am J Cardiol. 2000. PMID: 10793178 Review.

6

Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention.

O'shea JC, Madan M, Cantor WJ, Pacchiana CM, Greenberg S, Joseph DM, Kitt MM, Lorenz TJ, Tcheng JE. O'shea JC, et al. Among authors: cantor wj. Am Heart J. 2000 Dec;140(6):834-9. doi: 10.1067/mhj.2000.110458. Am Heart J. 2000. PMID: 11099985

7

Glycoprotein IIb/IIIa inhibitors: therapeutic applications in acute ST-segment elevation myocardial infarction.

Campbell KR, Cantor W, Sketch M, Ohman EM. Campbell KR, et al. Am Heart J. 2000 Dec;140(6 Suppl):S115-24. doi: 10.1067/mhj.2000.111612. Am Heart J. 2000. PMID: 11100005 Review. No abstract available.

8

Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women.

Cantor WJ, Miller JM, Hellkamp AS, Kramer JM, Peterson ED, Hasselblad V, Zidar JP, Newby LK, Ohman EM. Cantor WJ, et al. Am Heart J. 2002 Aug;144(2):297-302. doi: 10.1067/mhj.2002.123318. Am Heart J. 2002. PMID: 12177648

9

Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.

Cantor WJ, Goodman SG, Cannon CP, Murphy SA, Charlesworth A, Braunwauld E, Langer A. Cantor WJ, et al. Am Heart J. 2005 Feb;149(2):275-83. doi: 10.1016/j.ahj.2004.05.055. Am Heart J. 2005. PMID: 15846265 Clinical Trial.

10

Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction--the RADIAL-AMI pilot randomized trial.

Cantor WJ, Puley G, Natarajan MK, Dzavik V, Madan M, Fry A, Kim HH, Velianou JL, Pirani N, Strauss BH, Chisholm RJ. Cantor WJ, et al. Am Heart J. 2005 Sep;150(3):543-9. doi: 10.1016/j.ahj.2004.10.043. Am Heart J. 2005. PMID: 16169338 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page